A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

Lars Norgren, William R. Hiatt, John Dormandy et al. · Journal of Vascular Surgery · 2007 · 8.2K citations · Full text

Medicine, Cardiology, Surgery +15

ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)

Alan T. Hirsch, Ziv J. Haskal, Norman Hertzer et al. · Journal of Vascular and Interventional Radiology · 2006 · 460 citations · Full text

Medicine, Cardiology, Surgery +17

Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia

J. J. F. Belch, William R. Hiatt, Iris Baumgärtner et al. · The Lancet · 2011 · 336 citations · Full text

Medicine, Molecular Medicine, Gene Therapy +13

Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia

Sigrid Nikol, Iris Baumgärtner, Éric Van Belle et al. · Molecular Therapy · 2008 · 327 citations · Full text

Medicine, Pharmacotherapy, Surgery +17

Results of a Double-Blind, Placebo-Controlled Study to Assess the Safety of Intramuscular Injection of Hepatocyte Growth Factor Plasmid to Improve Limb Perfusion in Patients With Critical Limb Ischemia

Richard J. Powell, Michael Simons, Farrel O. Mendelsohn et al. · Circulation · 2008 · 307 citations · Full text

Medicine, Pharmacotherapy, Surgery +13